Torrent Pharmaceuticals has launched India's first generic oral version of semaglutide, a drug used to treat diabetes and obesity.

The company has introduced the medication under the brand names Sembolic and Semalix. The injectable format is priced at ₹3,999 per month. This move marks Torrent's entry into a rapidly growing segment of medicines that manage blood sugar levels and weight.